Phase Five

I tweet about PR’s of American healthcare companies.

Created by @kevinjaybe

[Phase Five @phasefivebot]

🚨Small service announcement🚨

Effective immediately we're moving to our own custom solution for tracking newly released PRs. So we will no longer depend on third party PR newswires sources.

This also means some companies will not be tracked for the time being.

[Phase Five @phasefivebot]

$PFE Pfizer and BioNTech Granted U.S. Emergency Use Authorization for Booster Dose of Their COVID-19 Vaccine in Children 5 Through 11 Years of Age https://t.co/F5rgM031ez

[Phase Five @phasefivebot]

$BNTX Pfizer and BioNTech Granted U.S. Emergency Use Authorization for Booster Dose of Their COVID-19 Vaccine in Children 5 Through 11 Years of Age https://t.co/EQFg0sUnD1

[Phase Five @phasefivebot]

$SRNE Sorrento’s License Partner, Lee’s Pharm, Announces Full Enrollment of 498 Patients in a Phase III Trial of Socazolimab (Anti-PD-L1 Antibody) for First-Line Treatment of Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) https://t.co/LJ0xdUUo1o

[Phase Five @phasefivebot]

$SRNE Sorrento Announces FDA Authorization to Proceed With Phase 2 Study of Abivertinib (Fujovee™) to Treat Metastatic Castrate Resistant Prostate Cancer (MAVERICK Trial) https://t.co/I8rZVU6lSi

[Phase Five @phasefivebot]

$INFI Infinity Pharmaceuticals to Participate in Upcoming H.C. Wainwright Global Investment Conference https://t.co/KUq7A0fdby

[Phase Five @phasefivebot]

$IDRA Idera Pharmaceuticals Shares Positive Results from Investigator-Sponsored Trial in Melanoma Patients at Amsterdam UMC https://t.co/yLPtxwzndY

[Phase Five @phasefivebot]

$CPRX Catalyst Pharmaceuticals to Participate in Two Upcoming Investor Conferences https://t.co/k7De1V4L66

[Phase Five @phasefivebot]

$FNCH Finch Therapeutics to Present at the H.C. Wainwright Global Investment Conference https://t.co/HS28Ww4GzJ

[Phase Five @phasefivebot]

$MORF Morphic Announces Participation in 2022 RBC Capital Markets Global Healthcare Conference https://t.co/vNbS8Nb8ud

[Phase Five @phasefivebot]

$RARE Ultragenyx Acquires Global Rights to AAV Gene Therapy ABO-102 for Sanfilippo Syndrome Type A (MPS IIIA) from Abeona Therapeutics https://t.co/yQ0S3YRGYG

[Phase Five @phasefivebot]

$SLNO Soleno Therapeutics to Participate in the H.C. Wainwright Global Investment Conference https://t.co/y7JKZdTQIF

[Phase Five @phasefivebot]

$MRUS Merus to Present at the H.C. Wainwright Global Investment Conference https://t.co/s8Fj6oA2jE

[Phase Five @phasefivebot]

$SCPH scPharmaceuticals to Present at the H.C. Wainwright Global Investment Conference https://t.co/Z1BhzFEkCi

[Phase Five @phasefivebot]

$HZNP Horizon Therapeutics plc Announces First Patient Enrolled in Phase 2 Trial Evaluating Daxdilimab (HZN-7734) for the Treatment of Alopecia Areata https://t.co/SVGJR1geO8

[Phase Five @phasefivebot]

$MDGL Madrigal Pharmaceuticals Announces Participation at Two Upcoming Investor Conferences https://t.co/vTGfD1n2XR

[Phase Five @phasefivebot]

$JNCE Jounce Therapeutics to Present at Upcoming Investor Conferences https://t.co/L2gzRyIN5n

[Phase Five @phasefivebot]

$ESPR Esperion to Participate in Upcoming H.C. Wainwright Global Investment Conference https://t.co/jQIQ5NLwql

[Phase Five @phasefivebot]

$ISEE Iveric Bio to Present at the UBS Global Healthcare Conference 2022 https://t.co/m1HDJBNNj8

[Phase Five @phasefivebot]

$INSM Insmed To Present at the H.C. Wainwright Annual Global Life Sciences Conference https://t.co/biUsheN0bQ

[Phase Five @phasefivebot]

$CABA Cabaletta Bio to Present at the H.C. Wainwright Global Investment Conference https://t.co/ge47pqE7mO